These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 38003343)

  • 1. The AKI-to-CKD Transition: The Role of Uremic Toxins.
    André C; Bodeau S; Kamel S; Bennis Y; Caillard P
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence.
    Chen JH; Chiang CK
    Toxins (Basel); 2021 Dec; 14(1):. PubMed ID: 35050985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Gut-Derived, Protein-Bound Uremic Toxins in the Cardiovascular Complications of Acute Kidney Injury.
    Caillard P; Bennis Y; Six I; Bodeau S; Kamel S; Choukroun G; Maizel J; Titeca-Beauport D
    Toxins (Basel); 2022 May; 14(5):. PubMed ID: 35622583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early elimination of uremic toxin ameliorates AKI-to-CKD transition.
    Chen JH; Chao CT; Huang JW; Hung KY; Liu SH; Tarng DC; Chiang CK
    Clin Sci (Lond); 2021 Dec; 135(23):2643-2658. PubMed ID: 34796904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uremic toxins in chronic kidney disease highlight a fundamental gap in understanding their detrimental effects on cardiac electrophysiology and arrhythmogenesis.
    van Ham WB; Cornelissen CM; van Veen TAB
    Acta Physiol (Oxf); 2022 Nov; 236(3):e13888. PubMed ID: 36148604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uremic toxins in acute kidney injury.
    Herget-Rosenthal S; Glorieux G; Jankowski J; Jankowski V
    Semin Dial; 2009; 22(4):445-8. PubMed ID: 19708999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two rapid, accurate liquid chromatography tandem mass spectrometry methods for the quantification of seven uremic toxins: An application for describing their accumulation kinetic profile in a context of acute kidney injury.
    André C; Bennis Y; Titeca-Beauport D; Caillard P; Cluet Y; Kamel S; Choukroun G; Maizel J; Liabeuf S; Bodeau S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122234. PubMed ID: 32615535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14-3-3ζ inhibits maladaptive repair in renal tubules by regulating YAP and reduces renal interstitial fibrosis.
    Wang TT; Wu LL; Wu J; Zhang LS; Shen WJ; Zhao YH; Liu JN; Fu B; Wang X; Li QG; Bai XY; Wang LQ; Chen XM
    Acta Pharmacol Sin; 2023 Feb; 44(2):381-392. PubMed ID: 35840657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From AKI to CKD: Maladaptive Repair and the Underlying Mechanisms.
    Wang Z; Zhang C
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of renin-angiotensin system in acute kidney injury-chronic kidney disease transition.
    Chou YH; Chu TS; Lin SL
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():121-125. PubMed ID: 30298669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?
    El Chamieh C; Liabeuf S; Massy Z
    Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Kidney Injury to Chronic Kidney Disease Transition.
    Fiorentino M; Grandaliano G; Gesualdo L; Castellano G
    Contrib Nephrol; 2018; 193():45-54. PubMed ID: 29393158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition.
    Lok SWY; Yiu WH; Zou Y; Xue R; Li H; Ma J; Chen J; Chan LYY; Lai KN; Tang SCW
    Nephrol Dial Transplant; 2023 Sep; 38(10):2232-2247. PubMed ID: 36914214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota dysbiosis in AKI to CKD transition.
    Saranya GR; Viswanathan P
    Biomed Pharmacother; 2023 May; 161():114447. PubMed ID: 37002571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel insights into acute kidney injury-chronic kidney disease continuum and the role of renin-angiotensin system.
    Chou YH; Huang TM; Chu TS
    J Formos Med Assoc; 2017 Sep; 116(9):652-659. PubMed ID: 28615146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebro-renal interactions: impact of uremic toxins on cognitive function.
    Watanabe K; Watanabe T; Nakayama M
    Neurotoxicology; 2014 Sep; 44():184-93. PubMed ID: 25003961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cognitive impairment and the blood-brain barrier in chronic kidney disease: role of the uremic toxins].
    Bobot M
    Nephrol Ther; 2023 Dec; 19(7):607-615. PubMed ID: 38059844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction and the AKI-to-CKD transition.
    Jiang M; Bai M; Lei J; Xie Y; Xu S; Jia Z; Zhang A
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1105-F1116. PubMed ID: 33073587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction.
    Fujii H; Goto S; Fukagawa M
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF or EGFR inhibition equally block AKI-to-CKD transition: opportunities for etanercept treatment.
    Abdelmageed MM; Kefaloyianni E; Arthanarisami A; Komaru Y; Atkinson JJ; Herrlich A
    Nephrol Dial Transplant; 2023 May; 38(5):1139-1150. PubMed ID: 36269313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.